Rephine is a pharmaceutical industry leader based in the United Kingdom. Established in 1998, the company has flourished over the past 25 years as a global authority in GxP compliance, providing auditing, consulting, and regulatory services to pharmaceutical, biotech, and medical device manufacturing supply chains. Their expertise and experience in quality assurance have positioned them as the Gold Standard within the industry. Through tailored service design, efficient use of technology, and consistent audit reporting, they have gained widespread recognition across worldwide markets.
Rephine's proactive approach involves assisting pharmaceutical and medical device companies with manufacturing and supply chain quality assurance, as well as business process optimization, reflecting their commitment to enhancing overall operational quality and efficiency. The company's extensive experience and deep understanding of GxP compliance have contributed to their stellar reputation and market presence.
There is no investment information
No recent news or press coverage available for Rephine.